Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors

Zsuzsa Bencsik, I. Szabolcs, Zsuzsa Kovács, Antal Ferencz, Attila Vörös, Ilona Kaszás, Katalin Bor, Judit Gönczi, M. Góth, László Kovács, O. Dohán, G. Szilágyi

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

To assess its differential diagnostic value, dehydroepiandrosterone sulfate (DHEA-S) was measured in a nonselected cohort of 84 patients with incidentally detected adrenal tumors (incidentaloma). Of the 38 histologically confirmed cases, 6 of 12 patients with primary or metastatic malignant tumor of the adrenals and 7 of 14 patients with benign cortical adenoma had low DHEA-S levels. Thus, the sensitivity, specificity, and predictive value of a low DHEA- S level to indicate a benign adrenal tumor were 0.35, 0.50, and 0.60, and the values to indicate a cortical adenoma were 0.50, 0.67, and 0.47, respectively. Of the 14 cases of histologically confirmed benign cortical adenoma, 10 had signs of hormonal activity, but DHEA-S was suppressed in only 7 cases. Thus, the sensitivity, specificity, and predictive value of a low DHEA-S level to indicate clinically significant hormonal activity of a benign cortical adenoma were 0.60, 0.75, and 0.86, respectively. For comparison, 5 of 5 males and 2 of 5 females with metastatic carcinomatosis, but without involvement of the adrenals, also had low DHEA-S levels. The data clearly show that in nonselected cases of incidentaloma a suppressed DHEA-S level is not a good predictor of hormonal activity and that DHEA-S measurement may be valuable only after having ascertained the cortical origin and benign feature of the tumor.

Original languageEnglish
Pages (from-to)1726-1729
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume81
Issue number5
DOIs
Publication statusPublished - 1996

Fingerprint

Dehydroepiandrosterone Sulfate
Glandular and Epithelial Neoplasms
Tumors
Adenoma
Sensitivity and Specificity
Dehydroepiandrosterone
Neoplasms
Carcinoma

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. / Bencsik, Zsuzsa; Szabolcs, I.; Kovács, Zsuzsa; Ferencz, Antal; Vörös, Attila; Kaszás, Ilona; Bor, Katalin; Gönczi, Judit; Góth, M.; Kovács, László; Dohán, O.; Szilágyi, G.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 81, No. 5, 1996, p. 1726-1729.

Research output: Contribution to journalArticle

Bencsik, Zsuzsa ; Szabolcs, I. ; Kovács, Zsuzsa ; Ferencz, Antal ; Vörös, Attila ; Kaszás, Ilona ; Bor, Katalin ; Gönczi, Judit ; Góth, M. ; Kovács, László ; Dohán, O. ; Szilágyi, G. / Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. In: Journal of Clinical Endocrinology and Metabolism. 1996 ; Vol. 81, No. 5. pp. 1726-1729.
@article{57a8eb096b50499a8639c860b574bcb4,
title = "Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors",
abstract = "To assess its differential diagnostic value, dehydroepiandrosterone sulfate (DHEA-S) was measured in a nonselected cohort of 84 patients with incidentally detected adrenal tumors (incidentaloma). Of the 38 histologically confirmed cases, 6 of 12 patients with primary or metastatic malignant tumor of the adrenals and 7 of 14 patients with benign cortical adenoma had low DHEA-S levels. Thus, the sensitivity, specificity, and predictive value of a low DHEA- S level to indicate a benign adrenal tumor were 0.35, 0.50, and 0.60, and the values to indicate a cortical adenoma were 0.50, 0.67, and 0.47, respectively. Of the 14 cases of histologically confirmed benign cortical adenoma, 10 had signs of hormonal activity, but DHEA-S was suppressed in only 7 cases. Thus, the sensitivity, specificity, and predictive value of a low DHEA-S level to indicate clinically significant hormonal activity of a benign cortical adenoma were 0.60, 0.75, and 0.86, respectively. For comparison, 5 of 5 males and 2 of 5 females with metastatic carcinomatosis, but without involvement of the adrenals, also had low DHEA-S levels. The data clearly show that in nonselected cases of incidentaloma a suppressed DHEA-S level is not a good predictor of hormonal activity and that DHEA-S measurement may be valuable only after having ascertained the cortical origin and benign feature of the tumor.",
author = "Zsuzsa Bencsik and I. Szabolcs and Zsuzsa Kov{\'a}cs and Antal Ferencz and Attila V{\"o}r{\"o}s and Ilona Kasz{\'a}s and Katalin Bor and Judit G{\"o}nczi and M. G{\'o}th and L{\'a}szl{\'o} Kov{\'a}cs and O. Doh{\'a}n and G. Szil{\'a}gyi",
year = "1996",
doi = "10.1210/jc.81.5.1726",
language = "English",
volume = "81",
pages = "1726--1729",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors

AU - Bencsik, Zsuzsa

AU - Szabolcs, I.

AU - Kovács, Zsuzsa

AU - Ferencz, Antal

AU - Vörös, Attila

AU - Kaszás, Ilona

AU - Bor, Katalin

AU - Gönczi, Judit

AU - Góth, M.

AU - Kovács, László

AU - Dohán, O.

AU - Szilágyi, G.

PY - 1996

Y1 - 1996

N2 - To assess its differential diagnostic value, dehydroepiandrosterone sulfate (DHEA-S) was measured in a nonselected cohort of 84 patients with incidentally detected adrenal tumors (incidentaloma). Of the 38 histologically confirmed cases, 6 of 12 patients with primary or metastatic malignant tumor of the adrenals and 7 of 14 patients with benign cortical adenoma had low DHEA-S levels. Thus, the sensitivity, specificity, and predictive value of a low DHEA- S level to indicate a benign adrenal tumor were 0.35, 0.50, and 0.60, and the values to indicate a cortical adenoma were 0.50, 0.67, and 0.47, respectively. Of the 14 cases of histologically confirmed benign cortical adenoma, 10 had signs of hormonal activity, but DHEA-S was suppressed in only 7 cases. Thus, the sensitivity, specificity, and predictive value of a low DHEA-S level to indicate clinically significant hormonal activity of a benign cortical adenoma were 0.60, 0.75, and 0.86, respectively. For comparison, 5 of 5 males and 2 of 5 females with metastatic carcinomatosis, but without involvement of the adrenals, also had low DHEA-S levels. The data clearly show that in nonselected cases of incidentaloma a suppressed DHEA-S level is not a good predictor of hormonal activity and that DHEA-S measurement may be valuable only after having ascertained the cortical origin and benign feature of the tumor.

AB - To assess its differential diagnostic value, dehydroepiandrosterone sulfate (DHEA-S) was measured in a nonselected cohort of 84 patients with incidentally detected adrenal tumors (incidentaloma). Of the 38 histologically confirmed cases, 6 of 12 patients with primary or metastatic malignant tumor of the adrenals and 7 of 14 patients with benign cortical adenoma had low DHEA-S levels. Thus, the sensitivity, specificity, and predictive value of a low DHEA- S level to indicate a benign adrenal tumor were 0.35, 0.50, and 0.60, and the values to indicate a cortical adenoma were 0.50, 0.67, and 0.47, respectively. Of the 14 cases of histologically confirmed benign cortical adenoma, 10 had signs of hormonal activity, but DHEA-S was suppressed in only 7 cases. Thus, the sensitivity, specificity, and predictive value of a low DHEA-S level to indicate clinically significant hormonal activity of a benign cortical adenoma were 0.60, 0.75, and 0.86, respectively. For comparison, 5 of 5 males and 2 of 5 females with metastatic carcinomatosis, but without involvement of the adrenals, also had low DHEA-S levels. The data clearly show that in nonselected cases of incidentaloma a suppressed DHEA-S level is not a good predictor of hormonal activity and that DHEA-S measurement may be valuable only after having ascertained the cortical origin and benign feature of the tumor.

UR - http://www.scopus.com/inward/record.url?scp=9344253814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344253814&partnerID=8YFLogxK

U2 - 10.1210/jc.81.5.1726

DO - 10.1210/jc.81.5.1726

M3 - Article

VL - 81

SP - 1726

EP - 1729

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -